why doesn't glp 1 work for me GLP-1 drugs, even when they fail, are giving researchers new insight about obesity : NPR Weight loss with GLP-1 medicines

Wang et al.'s report provides valuable quantitative information for the efficacy of l-carnitine supplementation on glycemic control in T2DM patients ( In the present study, a total of 10 RCT studies comprising 1,239 T2DM patients were included for analysis, including 8 studies of l-carnitine ( In further analysis of the effects of l-carnitine on Body Mass in T2DM patients, we found the E max of l-carnitine on BMI in T2DM patients was 1.51% and the ET 50 of l-carnitine on BMI in T2DM patients was 0.5 weeks

Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study

This systematic review aims to evaluate the effect of prolonged LC supplementation on metabolism and metabolic modifications

Because it says the two drug classes lower pressure through different mechanisms that add together: GLP-1 treatment through improved insulin sensitivity, weight loss, and vasodilation, and antihypertensives through angiotensin blockade, heart rate reduction, or vascular smooth muscle relaxation

[PMID: 16733230] PubMed record related to this compound for laboratory literature review

Also, timing and consistency greatly impact results